Sanofi-Aventis To Help Market Lilly’s Cialis Impotence Drug
Sanofi-Aventis (SNY) formed a collaboration with Eli Lilly & Co. (LLY) to help market Lilly’s erectile-dysfunction drug Cialis in the U.S.
A once-daily formulation of Cialis was approved by the U.S. Food and Drug Administration in January. Sales representatives for France-based Sanofi will promote once-daily Cialis to U.S. urologists. The drug is also available in an as-needed formulation, competing with Pfizer Inc.’s (PFE) Viagra.
The collaboration started March 13, a spokeswoman for Indianapolis-based Lilly said Tuesday. The companies agreed to a two-year collaboration, with an option to renew after that. Financial terms weren’t disclosed.
A Sanofi-Aventis spokesman couldn’t immediately be reached.
Bloomberg News reported the partnership earlier Tuesday.
Related posts:
- Eli Lilly’s Earnings Rise on Cialis
- FDA Approve 24/7 Cialis Therapy
- Once-a-day version of Lilly’s Cialis gets OK from FDA
- FDA approves daily Cialis doses
- FDA approves once-a-day Cialis
Comments
Leave a Reply
-
-
Recently Written
- Viagra and other fun with the health-care bill
- Cialis shown to help with muscle dystrophy
- Viagra aids in conceiving
- Virginia is for Viagra
- SIX MILLION MEN BUY VIAGRA ONLINE
- Viagra as a primary method of treatment of erectile dysfunction
- Generic Viagra will enable to get erection with Longer Effectiveness
- The Popularity Of Viagra Brings About A Cultural Change In Men
- Cialis Being Used To Treat Tumours
- Fake Viagra factory raided in Israel
-
Categories
